review · Medicine
Anemia, iron metabolism, and human immunodeficiency virus (HIV) are intricately connected through multiple biological pathways. Chronic inflammation caused by HIV disrupts how the body regulates iron, directly impairing red blood cell production and triggering anemia. In addition, the virus itself impacts bone marrow function, which further reduces red blood cell counts. While antiretroviral therapy is vital for controlling HIV infection, certain regimens can also cause medication-induced anemia. Furthermore, iron levels become dysregulated across different tissues. Managing anemia in people living with HIV therefore requires a multifaceted clinical strategy, including the refinement of antiretroviral regimens, treating opportunistic infections, and providing targeted nutritional support such as iron supplementation. Gaining a deeper understanding of the precise molecular mechanisms governing these relationships is essential for developing more tailored therapeutic strategies to improve overall patient care.
Anemia is a significant complication for people living with HIV, yet treating it is challenging because both the infection and its treatments disrupt iron balance. Understanding how viral activity, drug side effects, and nutritional status interact helps clinicians design better treatment plans, ultimately improving health outcomes and standard of care for affected individuals.
This work highlights foundational pathways that could inform the future design of targeted therapeutics, diagnostic monitoring tools, and refined nutritional interventions for managing HIV-associated anemia. The primary potential users are clinical researchers, pharmaceutical developers, and healthcare providers. Because the underlying molecular mechanisms remain incompletely understood, this research represents an early-stage review rather than an applied or near-market solution, indicating that substantial preclinical investigation is still required before clinical translation.
AI-generated from the published abstract. Always read the original work before citing.
This review delves into the intricate relationship between anemia, iron metabolism, and human immunodeficiency virus (HIV), aiming to unravel the interconnected pathways that contribute to the complex interplay between these 3 entities. A systematic exploration of relevant literature was conducted, encompassing studies examining the association between anemia, iron status, and HIV infection. Both clinical and preclinical investigations were analyzed to elucidate the underlying mechanisms linking these components. Chronic inflammation, a hallmark of HIV infection, disrupts iron homeostasis, impacting erythropoiesis and contributing to anemia. Direct viral effects on bone marrow function further compound red blood cell deficiencies. Antiretroviral therapy, while essential for managing HIV, introduces potential complications, including medication-induced anemia. Dysregulation of iron levels in different tissues adds complexity to the intricate network of interactions. Effective management of anemia in HIV necessitates a multifaceted approach. Optimization of antiretroviral therapy, treatment of opportunistic infections, and targeted nutritional interventions, including iron supplementation, are integral components. However, challenges persist in understanding the specific molecular mechanisms governing these interconnected pathways. Decoding the interconnected pathways of anemia, iron metabolism, and HIV is imperative for enhancing the holistic care of individuals with HIV/AIDS. A nuanced understanding of these relationships will inform the development of more precise interventions, optimizing the management of anemia in this population. Future research endeavors should focus on elucidating the intricate molecular mechanisms, paving the way for innovative therapeutic strategies in the context of HIV-associated anemia.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1097/md.0000000000036937
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
